| |
| |
|
| Insider
Information: |
Campbell Bradley L |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
886,654 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,407,399 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
886,654 |
|
|
| Total
Value |
$9,407,399 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-05-01 |
886,654 |
2014-04-10 |
0 |
Premium* |
|
|
Progenics Pharmaceuticals Inc |
PGNX |
Director |
2020-06-19 |
0 |
2019-07-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-05-01 |
4 |
S |
$10.07 |
$75,524 |
D/D |
(7,500) |
886,654 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-05-01 |
4 |
OE |
$8.61 |
$64,575 |
D/D |
7,500 |
894,154 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-04-01 |
4 |
S |
$11.67 |
$87,496 |
D/D |
(7,500) |
886,654 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-04-01 |
4 |
OE |
$8.61 |
$64,575 |
D/D |
7,500 |
894,154 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-03-15 |
4 |
D |
$11.48 |
$153,545 |
D/D |
(13,375) |
886,654 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-03-01 |
4 |
S |
$13.14 |
$208,017 |
D/D |
(15,833) |
871,219 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-03-01 |
4 |
OE |
$8.61 |
$166,904 |
D/D |
15,833 |
887,052 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-02-15 |
4 |
S |
$14.00 |
$58,338 |
D/D |
(4,167) |
871,219 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-02-01 |
4 |
OE |
$8.61 |
$166,904 |
D/D |
15,833 |
891,219 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-02-01 |
4 |
S |
$12.56 |
$198,858 |
D/D |
(15,833) |
875,386 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-09 |
4/A |
A |
$0.00 |
$0 |
D/D |
28,810 |
927,773 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-09 |
4/A |
D |
$13.65 |
$321,826 |
D/D |
(23,577) |
904,196 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-09 |
4 |
D |
$13.65 |
$321,826 |
D/D |
(23,577) |
875,386 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-04 |
4 |
D |
$13.44 |
$99,026 |
D/D |
(7,368) |
898,963 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-03 |
4 |
D |
$13.53 |
$561,143 |
D/D |
(41,474) |
906,331 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
153,810 |
963,257 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-02 |
4 |
D |
$14.24 |
$220,036 |
D/D |
(15,452) |
947,805 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-02 |
4 |
OE |
$8.61 |
$166,904 |
D/D |
15,833 |
956,138 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2024-01-02 |
4 |
S |
$14.23 |
$225,380 |
D/D |
(15,833) |
947,805 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2023-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
17,286 |
809,447 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2023-12-01 |
4 |
S |
$11.08 |
$129,693 |
D/D |
(11,702) |
792,161 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2023-12-01 |
4 |
OE |
$2.94 |
$34,404 |
D/D |
11,702 |
803,863 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2023-10-02 |
4 |
OE |
$2.94 |
$34,398 |
D/D |
11,700 |
803,861 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2023-10-02 |
4 |
S |
$11.20 |
$131,489 |
D/D |
(11,700) |
792,161 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2023-09-01 |
4 |
S |
$12.97 |
$234,648 |
D/D |
(18,093) |
792,161 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
